Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

REPROS THERAPEUTICS INC. (RPRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-17Jun-30-17Mar-31-17Dec-31-16Sep-30-16Jun-30-16Mar-31-16Dec-31-15
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenues and other income          
Interest income  0.00.00.00.00.00.00.00.0
Change in fair value of warrant liability  0.30.2      
    Total revenues and other income  0.30.00.00.00.00.00.00.0
            Total revenues and other income growth  2940.0%-53.3%-58.8%-25.0%900.0%1400.0%1600.0%300.0%
Expenses          
Research and development  1.01.12.12.63.23.23.84.8
General and administrative  0.90.93.81.41.01.11.11.4
    Total expenses  1.92.25.94.04.24.34.96.3
    Net loss  -1.6-2.2-5.9-4.0-4.2-4.3-4.8-6.3
   
Basic and diluted loss per share  ($0.04)($0.08)($0.22)($0.15)($0.17)($0.18)($0.20)($0.26)
   
Shares used in loss per share calculation:          
Basic  37.628.426.3 24.524.324.3 
   
Diluted  37,598.028,398.026,270.024.724.524,319.024.324.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy